Our findings highlight the importance of personalized dietary intervention strategies in the prevention and management of NAFLD, reveal two potential therapeutic targets, FTO and DNER, and provide new directions for clinical treatment of NAFLD. This evidence concerns the gene FTO and metabolic dysfunction-associated steatotic liver disease.